Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome

2015

Journal of Alzheimer's Disease , Volume 45 - Issue 3 p. 733- 743

Additional Metadata
Keywords	Alzheimer's disease, amyloid-β, apolipoprotein E, biomarker, down syndrome, inflammation, lipocalin 2, platelets
Persistent URL	doi.org/10.3233/JAD-142514, hdl.handle.net/1765/88093
Journal	Journal of Alzheimer's Disease
Organisation	Department of Epidemiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Naudé, P.J.W, Dekker, A.D, Coppus, A.M.W, Vermeiren, Y, Eisel, U.L.M, van Duijn, C.M, … de Deyn, P.P. (2015). Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome. Journal of Alzheimer's Disease, 45(3), 733–743. doi:10.3233/JAD-142514

Publication